Websites using Cardiachill

Let s break down Cardiachill, a medical device used for Targeted Temperature Management (TTM). Here s an overview covering its purpose, potential revenue context, alternatives, pricing considerations, and customer care aspects:

Cardiachill Overview

• What it is: Cardiachill is a non-invasive, surface-based cooling system manufactured by ZOLL Medical Corporation. It s designed for Targeted Temperature Management (TTM), also known as therapeutic hypothermia or therapeutic temperature modulation.

• Purpose/Function: Cardiachill s primary function is to rapidly and precisely control a patient s body temperature. This is crucial in various clinical scenarios, particularly after:

  • Cardiac Arrest: To improve neurological outcomes after resuscitation from cardiac arrest by inducing and maintaining hypothermia (cooling the body). This helps protect the brain from damage caused by oxygen deprivation during the arrest and reperfusion injury after blood flow is restored.
  • Stroke: In some cases of stroke, particularly ischemic stroke, hypothermia may be used to reduce brain damage.
  • Traumatic Brain Injury (TBI): TTM can help manage intracranial pressure and reduce secondary brain injury in TBI patients.
  • Other Conditions: TTM might be used in other situations where temperature control is critical, such as sepsis or certain neurological conditions, as directed by clinical protocols.

• How it works: Cardiachill utilizes hydrogel pads applied to the patient s skin. These pads are connected to a console that circulates chilled water. The system allows clinicians to:

  • Rapidly cool the patient to a target temperature.
  • Maintain a precise and stable temperature for a defined period.
  • Slowly rewarm the patient to normal body temperature at a controlled rate.
  • Normothermia Maintenance: It can also be used to maintain normal body temperature (normothermia) and prevent fever in critically ill patients.

• Key Features often highlighted by ZOLL:

  • Non-invasive: Reduces the risks associated with invasive cooling methods (like intravascular catheters).
  • Precise Temperature Control: Allows for accurate and stable temperature management.
  • Rapid Cooling and Rewarming: Designed for efficient temperature modulation.
  • Ease of Use: User-friendly interface and setup for medical staff.
  • Integrated Monitoring: Often integrated with patient monitoring systems.
  • Data Logging: Records temperature data for documentation and analysis.

Revenue Context

• Not Publicly Disclosed for Cardiachill Alone: ZOLL Medical Corporation is a subsidiary of Asahi Kasei Corporation, a publicly traded company. However, specific revenue figures for individual products like Cardiachill are not typically broken out and publicly disclosed. ZOLL s revenue is reported as part of Asahi Kasei s broader healthcare business segment.

• Estimating Revenue Context (General Industry Trends):

  • TTM Market Growth: The market for Targeted Temperature Management devices is generally growing due to increasing awareness of the benefits of TTM in critical care, especially post-cardiac arrest, and expanding applications.
  • ZOLL s Position: ZOLL is a well-established and reputable company in the medical device space, particularly known for resuscitation and critical care technologies. Cardiachill is likely a significant product within their TTM portfolio, contributing to their overall revenue in the critical care segment.
  • Factors Influencing Revenue: Revenue for Cardiachill (and similar devices) would be driven by:
    • Hospital adoption rates: How many hospitals are implementing TTM protocols and choosing Cardiachill.
    • Volume of patients requiring TTM: Prevalence of conditions like cardiac arrest, stroke, and TBI influences demand.
    • Replacement and consumables: Hydrogel pads are consumable supplies that generate recurring revenue.
    • Service and maintenance contracts: ZOLL likely offers service and maintenance plans, contributing to revenue.

• To get specific revenue insights: You would need to look at Asahi Kasei s investor relations materials, annual reports, and financial presentations. However, even there, you re unlikely to find a precise figure for Cardiachill alone. Industry market research reports (often subscription-based) focused on TTM devices might provide broader market size and growth estimates that could offer some context.

Alternatives to Cardiachill

Cardiachill is a surface cooling system. Alternatives fall into a few categories:

• Other Surface Cooling Systems:

  • Arctic Sun 5000 (Stryker): A very common and well-regarded surface cooling system, often considered a direct competitor to Cardiachill. It also uses hydrogel pads and a console to circulate coolant.
  • Blanketrol III Hyper-Hypothermia System (Cincinnati Sub-Zero Products, Inc.): Uses blankets filled with fluid for cooling or warming. A more traditional approach, but still used.
  • Cool-Line Catheter System (BD): While BD also makes intravascular catheters (below), they also have surface cooling options.
  • Simple methods like ice packs and cooling blankets: These are less precise and less controlled than dedicated systems like Cardiachill and Arctic Sun, but may be used in resource-limited settings or for less critical temperature management needs.

• Intravascular Cooling Systems: These are more invasive but often achieve faster cooling rates. They involve inserting a catheter into a large vein (e.g., femoral or subclavian) with a cooling element at the tip.

  • Thermogard XP (ZOLL): Ironically, ZOLL themselves makes an intravascular cooling system, so it s an alternative within the ZOLL portfolio.
  • CoolGard System (Zimmer Biomet): Another prominent intravascular cooling system.
  • InnerCool RTx System (Philips): Philips also offers intravascular TTM solutions.

• Pharmacological Approaches (Adjuncts): While not direct alternatives for cooling devices, certain medications (like sedatives and paralytics) can help reduce shivering and improve the effectiveness of cooling.

Pricing

• Highly Variable and Not Publicly Listed: Medical device pricing, especially for capital equipment like Cardiachill, is not publicly listed. Pricing is determined through a complex process and is highly variable based on:

  • Hospital or Healthcare System Size and Purchasing Power: Large hospital networks often negotiate better pricing due to volume commitments.
  • Contract Terms: Lease vs. purchase, service agreements, bundled deals.
  • Configuration and Accessories: The specific Cardiachill configuration and any additional accessories or features desired.
  • Geographic Location and Distribution Channels: Pricing can vary by region.
  • Competition: Competitive pressure from alternative systems (like Arctic Sun) can influence pricing.

• Pricing Model - Likely Capital Equipment with Consumables:

  • Initial Capital Purchase: Hospitals would purchase the Cardiachill console/system. This is a significant capital expenditure.
  • Recurring Consumables: Hydrogel pads are disposable and need to be replaced for each patient. This generates ongoing consumable revenue for ZOLL.
  • Service and Maintenance Contracts: Hospitals may opt for service contracts to ensure maintenance, repairs, and potentially training, which adds to the overall cost over time.

• How to Get Pricing Information: Hospitals or healthcare facilities interested in Cardiachill need to contact ZOLL Medical directly or their authorized distributors to request a quote. They will likely need to provide information about their specific needs and purchasing volume.

Customer Care Details (ZOLL Medical)

• Reputation for Customer Support: ZOLL Medical is generally known for having a strong customer support and service infrastructure, typical of established medical device companies.

• Likely Customer Care Components:

  • Technical Support: For troubleshooting, system issues, and operational questions. This would likely be available via phone, online, and potentially on-site support.
  • Training: ZOLL provides training to hospital staff on how to properly use and maintain Cardiachill. This is crucial for safe and effective operation. Training may be on-site, online, or at ZOLL training centers.
  • Service and Maintenance: Options for preventative maintenance, repairs, and calibration. Service contracts are often available.
  • Clinical Support: In some cases, ZOLL may offer clinical support to help hospitals implement TTM protocols and optimize device usage within their clinical pathways.
  • Parts and Supplies: Easy access to order replacement hydrogel pads and other necessary supplies.
  • Warranty: Cardiachill would come with a warranty, the terms of which would be part of the purchase agreement.
  • Online Resources: ZOLL likely has online resources like product manuals, FAQs, and possibly online training modules for Cardiachill on their website.

• How to Access Customer Care:

  • ZOLL Website: The primary point of contact is the ZOLL Medical website. Look for Support, Service, Contact Us, or similar sections. You ll find phone numbers, email addresses, and potentially online support portals.
  • Dedicated Phone Lines: ZOLL likely has specific phone lines for technical support and customer service.
  • Local Distributors: In some regions, hospitals may work through local medical device distributors who also provide a level of front-line customer support and liaison with ZOLL.

In Summary

Cardiachill is a valuable non-invasive tool for Targeted Temperature Management, particularly in post-cardiac arrest care. While precise revenue figures are not public, it s likely a contributing product within ZOLL s successful critical care business. Alternatives exist in both surface and intravascular cooling systems. Pricing is highly negotiated and not publicly disclosed, and ZOLL is expected to provide robust customer care typical of a leading medical device manufacturer. For specific pricing or detailed customer care information, contacting ZOLL Medical directly is essential.